Häftad, Engelska, 2027
Euphorbiaceae Family Oriented Drug Discovery
Exploration of Isolation, Identification, Total Synthesis, and Drug Discovery Based on Natural Products from Euphorbiaceae Family
Av Bingjie Li, Linlin Shi
Del i serien Drug Discovery Opinions
2327 kr
Kommande
Beskrivning
The next chapters focus on specific techniques for identification and synthesis of natural products, cover the antitumor activities and mechanisms of action of natural products, and discuss the specific antimicrobial properties and mechanisms of action. Final sections discuss anti-inflammatory properties, pharmacology, drug discovery processes for Euphorbiaceae Natural Products, and describe challenges and future directions in research. The final chapter presents final considerations, summarizing key findings and insights from the book.
- Provides a comprehensive overview of the entire process, from isolation and identification to synthesis and drug discovery from the Euphorbiaceae family of plants
- Presents coverage of interdisciplinary areas and scientific disciplines, including botany, chemistry, pharmacology, and biotechnology
- Offers insights into future directions and perspectives, highlighting emerging research areas and potential new leads within the Euphorbiaceae family
Produktinformation
- Utgivningsdatum: 2027-05-01
- Mått: 191 x 235 x undefined mm
- Vikt: 450 g
- Format: Häftad
- Språk: Engelska
- Serie: Drug Discovery Opinions
- Antal sidor: 500
- Förlag: Elsevier Science
- ISBN: 9780443449383
Utforska kategorier
Mer om författaren
Professor Bingjie Li is a scholar with extensive expertise in chemistry, clinical medicine, nanotechnology, and biomedical research. He completed advanced studies at renowned institutions, including the University of Oxford and Monash University, specializing in nanotechnology and palliative care, and earned a Ph.D. in Clinical Medicine from Zhengzhou University, where his research focused on inorganic chemistry and translational medicine. Professor Li has made significant contributions to nanotechnology and biomedical research, particularly through pioneering work on innovative nanomaterials for therapeutic applications in cancer and cardiovascular diseases. Linlin Shi is a Professor of Organic Chemistry at Zhengzhou University in Henan. He received his Ph.D. degree in Organic Chemistry from Peking University in 2019 under the supervision of Prof. Zhen Yang and Prof. Jianxian Gong. In 2020, he began his independent academic career at the College of Chemistry at Zhengzhou University. He is working on the total synthesis of anticancer and antibacterial natural products and functional molecules. He has published about 60 SCI papers and co-invented 10 patents. He currently serves as editorial Board Member of Chemical Synthesis, Green Synthesis and Catalysis, Exploration, Chinese Chemical Letters, etc.
Betyg & recensioner
0 recensioner
Inga recensioner tillgängliga.